ONL Therapeutics, Inc.

Ann Arbor, MI 48109

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.91MM
First Award Date 09/01/14
Most Recent Award Date 04/01/17

Key Personnel

Last Name Name Awards Contact
JAMISON JEFFREY A JAMISON 1
JOHNSON LINDA LEA JOHNSON 2
VAN DE GOOR JANA VAN DE GOOR 1

4 Awards Won

Phase SBIR

Agency: Department of Health & Human Services
Topic: PAR-16-027
Budget: 04/01/17 - 03/31/18

PROJECT SUMMARY / ABSTRACT Retinal degenerative disease and injury are among the leading causes of irreversible vision loss and blindness in the United States and the developed world, affecting hundreds of thousands of people every year and resulting in billions of dollars in added healthcare costs and lost productivity. Photoreceptor cell deat...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-132
Budget: 09/01/15 - 08/31/16

DESCRIPTION (provided by applicant): Death of photoreceptor cells is a consequence of many acute as well as chronic retinal diseases which lead to severe vision loss in patients. If photoreceptors could be helped to survive the period of disease, the visual outcomes for patients would be significantly better. Retinal degenerative disease and in...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 09/01/14 - 08/31/15

DESCRIPTION (provided by applicant): Death of photoreceptor cells is a consequence of many acute as well as chronic retinal diseases which lead to severe vision loss in patients. If photoreceptors could be helped to survive the period of disease, the visual outcomes for patients would be significantly better. Retinal degenerative disease and in...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 09/01/14 - 08/31/15

DESCRIPTION (provided by applicant): Death of photoreceptor cells is a consequence of many acute as well as chronic retinal diseases which lead to severe vision loss in patients. If photoreceptors could be helped to survive the period of disease, the visual outcomes for patients would be significantly better. Retinal degenerative disease and in...